Bio Vitos Pharma Stock

BIOVIT

SE0023286919

Medical Equipment, Supplies & Distribution

Latest news : Bio Vitos Pharma

25-03-25	Alerts on Bio Vitos Pharma withdrawn	RE
25-03-17	Bio Vitos Pharma is delisted from First North with last trading day April 11	FW
25-02-28	Bio Vitos Pharma AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2024	CI
24-12-13	Nasdaq wants Bio Vitos Pharma delisted after deficiencies in information disclosure	FW
24-11-15	Bio Vitos Pharma AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024	CI
24-09-12	Bio Vitos Pharma signs exclusive distribution agreement in the Balkans	FW
24-08-30	Bio Vitos Pharma AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024	CI
24-05-13	Bio Vitos Pharma AB Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
24-02-14	Bio Vitos Pharma AB Reports Earnings Results for the Full Year Ended December 31, 2023	CI
24-02-14	Bio Vitos Pharma AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	CI
24-02-12	Bio Vitos Pharma Teams Up with KFUM Kalmar to Explore Benefits of Iron Succinate for Female Athletes	MT
24-02-12	KFUM Kalmar and Bio Vitos Pharma Sign Collaboration Agreement to Conduct Research Study on Succifer	CI
23-12-20	The European Patent Office EPO Grants Patent to Bio Vitos Pharma AB	CI

More news

Press Releases: Bio Vitos Pharma

24-11-13	Bio Vitos Pharma AB (publ) appoints LAGO KAPITAL as liquidity provider	AQ
24-02-12	KFUM Kalmar and Bio Vitos Pharma enter into an agreement regarding a research study on Succifer	AQ
23-12-20	The European Patent Office EPO grants patent that is important to Bio Vitos Pharma	AQ
23-10-20	Hemcheck completes the transaction with Bio Vitos	AQ
23-05-15	Hemcheck has received a first order from its distributor Astemed	AQ

More press releases

Managers and Directors: Bio Vitos Pharma

Manager	Title	Age	Since
Sven Rohmann CEO	Chief Executive Officer	64	2024-12-31
Joen Averstad CEO	Chief Executive Officer	42	2019-05-14
Jon Jesper Birgemo CEO	Chief Executive Officer	49	2022-12-31

Director	Title	Age	Since
Richard Wall CHM	Chairman	63	2022-12-31
Bo Ziedén BRD	Director/Board Member	63	2022-12-31
Igor Lokot BRD	Director/Board Member	54	2022-12-31

More insiders

Diagnostic & Testing Substances

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
BIO VITOS PHARMA	-4.00%	+8.60%	-	-	504K
GUARDANT HEALTH, INC.	+0.56%	-2.61%	+235.49%	+310.94%	20.67B
BIOMÉRIEUX	+0.41%	+4.58%	-38.34%	-22.44%	9.85B
LANTHEUS HOLDINGS, INC.	+2.36%	+1.85%	+53.31%	+20.60%	7B
10X GENOMICS, INC.	-1.66%	+2.36%	+260.00%	-27.26%	5.55B
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.	+0.36%	+3.63%	-17.20%	-23.46%	5.23B
ANDON HEALTH CO., LTD.	+10.00%	+34.69%	+101.94%	+124.62%	4.9B
CARIS LIFE SCIENCES, INC.	+0.06%	-2.94%	-45.38%	-	4.66B
DIASORIN S.P.A.	0.00%	+0.73%	-23.40%	-26.19%	4.2B
AUTOBIO DIAGNOSTICS CO., LTD.	-2.66%	+4.71%	-15.83%	-39.84%	2.72B
Average	+0.54%	+5.83%	+56.73%	+39.62%	7.2B
Weighted average by Cap.	+1.03%	+3.67%	+98.20%	+107.56%

See all sector performances

Bio Vitos Pharma AB, formerly Hemcheck Sweden AB, is a Sweden-based medical technology company. The Company produces and commercializes a service for near-patient detection of hemolysis in blood samples. The concept consists of disposable tests as well as readers that can quickly, directly upon sampling, identify hemolysed blood samples in vacuum tubes and blood gas syringes. The Company's, ruptured red blood cells, is a common reason globally why blood samples cannot be analyzed accurately and is also a biomarker for acute medical conditions. Its goal is to contribute to improved healthcare by offering user-friendly solutions for the detection of hemolysed blood samples in direct connection with blood sampling near the patient. By doing so, the Company can contribute to increased patient safety, more efficient processes and lower costs.

Employees

Sector

Medical Equipment, Supplies & Distribution

More about the company